Fusako Niimi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A Literature Review and Management Approach for Severe Skin Toxicity Induced by Enfortumab Vedotin Through Sequential Adaptation and Combination With Immune Checkpoint Inhibitors.

A Literature Review and Management Approach for Severe Skin Toxicity Induced by Enfortumab Vedotin Through Sequential Adaptation and Combination With Immune Checkpoint Inhibitors.

Journal: Cureus

Published: August 06, 2025

Port-Site Seeding of Urothelial Carcinoma After Robotic-Assisted Radical Prostatectomy Accompanied With Elevated Serum Levels of Carbohydrate Antigen 19-9: A Case Report.

Port-Site Seeding of Urothelial Carcinoma After Robotic-Assisted Radical Prostatectomy Accompanied With Elevated Serum Levels of Carbohydrate Antigen 19-9: A Case Report.

Journal: Case reports in urology

Published: May 09, 2025

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.

Journal: Immunotherapy

Published: May 16, 2023

Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma.

Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma.

Journal: Case reports in urology

Published: March 26, 2021

Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report.

Cerebral metastasis during remission after immunotherapy for metastatic urothelial carcinoma: A case report.

Journal: Molecular and clinical oncology

Published: January 16, 2021

Submucosal urothelial bladder cancer: A case report.

Submucosal urothelial bladder cancer: A case report.

Journal: Molecular and clinical oncology

Published: September 02, 2020

Safety of same-day administration of gemcitabine plus cisplatin chemotherapy for urothelial carcinoma.

Safety of same-day administration of gemcitabine plus cisplatin chemotherapy for urothelial carcinoma.

Journal: Molecular and clinical oncology

Published: July 03, 2020

Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report.

Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case report.

Journal: Oncology letters

Published: September 02, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026